Register your Account

Sign Up with us and Enjoy!
User nameEmailFirst NameLast NameContact info

A password will be e-mailed to you.

Stocks in The News: Overstock.com, Inc., Huntsman Corporation, Amyris Inc., AllianceBernstein Holding, Mellanox Technologies, Ltd.


NEW YORK, February 12, 2013 (MESHPRESS) – Csrnewsdaily.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following Tuesday’s Top Gainers:-

Overstock.com, Inc. (NASDAQ:OSTK) declined 2.03% to $12.58 on a traded volume of 16k shares. The Company announced that its CEO and Chairman of the Board Dr. Patrick Byrne will be taking a personal leave of absence for medical reasons. Overstock.com President Jonathan Johnson will serve as Acting CEO during Dr. Byrne’s leave of absence. Dr. Byrne will remain Chairman of the Board.

Get Free Trend Analysis on To Know More About MELA Here

Huntsman Corporation (NYSE:HUN) slipped 3.93% to $18.32 on a traded volume of 994k shares. The Company announced fourth quarter and year end results. Net income attributable to Huntsman Corporation in fiscal year was $363 million compared to $247 million in the prior year period. Adjusted EBITDA improved 15% to $1,396 million. Adjusted diluted income per share improved 33% to $2.25for the year. The adjusted EBITDA was $233 million in the fourth quarter compared to $243 million in the prior year period. Adjusted diluted income per share was $0.24 compared to $0.28 in the prior year period.

How Should Investors Trade ORIG Now? Find Out Here

Amyris Inc. (NASDAQ:AMRS) decreased 12.01% to $3.37 on a traded volume of 122k shares. Raymond James lowered the rating on Amyris, Inc. from Market Perform to Underperform.

How Should Investors React to WNS Now? Find Out Here

AllianceBernstein Holding LP (NYSE:AB) went down 2.33% to $20.94 on a traded volume of 245k shares. The Company announced fourth quarter results. Net revenues rose 13% to $705 million driven by higher distribution revenue on non-US retail products, higher retail base fees, higher performance fees on the Company’s fund of funds offerings and higher Bernstein Research Services revenues. The diluted net income per unit for the fourth quarter of 2012 was $0.26 compared to ($1.97) in the fourth quarter of 2011.

Get Free Trend Analysis on To Know More About MELA Here

Mellanox Technologies, Ltd. (NASDAQ:MLNX) slipped 1.90% to $52.37 on a traded volume of 271k shares. Rigrodsky & Long, P.A. announced that a complaint has been filed in the United States District Court for the Southern District of New York on behalf of all persons or entities that purchased the common stock of Mellanox Technologies, Ltd.

How Should Investors Trade ORIG Now? Find Out Here

About Csrnewsdaily.com

Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.

Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.

Disclaimer:

The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.

Contact:

Csrnewsdaily.com

info@csrnewsdaily.com

 

Related Press realease: